Viewing Study NCT00283959


Ignite Creation Date: 2025-12-24 @ 2:46 PM
Ignite Modification Date: 2026-04-11 @ 8:45 PM
Study NCT ID: NCT00283959
Status: COMPLETED
Last Update Posted: 2018-10-31
First Post: 2006-01-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease
Sponsor: Amicus Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fabry Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Amicus Therapeutics View
None AT1001 View
None Galafold View
None Migalastat View
None Substrate View